TL;DR

Key Facts

What Is It?

Pulp therapy medicaments are the pharmacological agents applied to the pulp space, pulp wound, or dentinal surfaces during endodontic procedures. They serve functions ranging from tissue dissolution (sodium hypochlorite), smear layer removal (EDTA), bacterial killing (calcium hydroxide, NaOCl), reparative hard tissue stimulation (MTA, Biodentine, calcium hydroxide), and haemostasis (ferric sulfate). Each agent’s mechanism of action, concentration dependency, tissue toxicity profile, and interactions with other agents must be understood to use them safely and effectively.

Why It Matters

Questions about endodontic medicaments appear consistently on the INBDE, testing knowledge of: which agent to use in which clinical scenario, what concentration is appropriate, what can go wrong when an agent is misused (e.g., NaOCl extrusion, EDTA-NaOCl interaction), and why one agent is preferred over another (e.g., MTA over CaOH for DPC). This article consolidates the key medicament profiles as a comparative reference.

MTA — Mineral Trioxide Aggregate

Composition and Setting

MTA (ProRoot MTA, Dentsply Sirona) is a calcium silicate-based hydraulic cement. Its composition includes tricalcium silicate (3CaO·SiO₂), dicalcium silicate (2CaO·SiO₂), tricalcium aluminate (3CaO·Al₂O₃), calcium sulfate dihydrate (gypsum), and bismuth oxide (radiopacifier). When mixed with water, calcium silicate undergoes hydration to form calcium silicate hydrate (C-S-H) gel and calcium hydroxide — the latter releasing Ca²⁺ and OH⁻ ions that drive the biological response.

• pH: Approximately 12.5 during setting (similar to calcium hydroxide). Highly alkaline, antibacterial.
• Setting time: 2.5–4 hours for original formulations. Moisture accelerates setting — can be placed in a slightly moist environment. Do not contaminate with blood before initial set.
• Radiopacity: Bismuth oxide renders MTA radiopaque. This allows radiographic identification post-placement.
• Grey vs White MTA: Grey MTA (ProRoot Grey) contains iron compounds that produce grey discolouration — avoid in anterior teeth where discolouration is visible. White MTA and Biodentine are preferred anteriorly.

Clinical Uses

• Direct pulp capping — primary indication; stimulates odontoblast-like cell differentiation and dense dentine bridge formation
• Partial and full coronal pulpotomy — placed over the radicular pulp wound
• Primary tooth pulpotomy — preferred agent per current AAPD guidelines
• Apical barrier / apexification — 3–5 mm MTA plug placed at open apex before obturation in non-vital immature teeth
• Perforation repair — furcal and lateral root perforations (provides seal and biocompatibility with PDL)
• Root-end filling in apicoectomy — retrograde fill after root-end resection; gold standard
• Resorption management — internal resorption repair after perforation; external inflammatory resorption as a repair material

Biodentine

Biodentine (Septodont) is a tricalcium silicate-based material with similar biological properties to MTA but with important handling advantages. Its powder contains tricalcium silicate, dicalcium silicate, calcium carbonate, and zirconium oxide (radiopacifier); the liquid is an aqueous solution of calcium chloride (accelerator) and polycarboxylate (water-reducing agent).

• Setting time: Approximately 12 minutes — significantly faster than MTA, reducing technique sensitivity
• Colour: White — no discolouration risk; preferred for anterior teeth and when aesthetics matter
• Biocompatibility: Similar to MTA — stimulates odontoblast-like differentiation, produces calcium silicate hydrate and calcium hydroxide on hydration, releases Ca²⁺ and OH⁻
• Compressive strength: Higher than MTA — approaches that of dentine; can act as a dentine substitute for coronal build-up in some protocols
• Clinical uses: Identical to MTA — DPC, pulpotomy, apexification, perforation repair, retrograde fill. Increasingly preferred over MTA in contemporary practice due to handling advantages
• Limitation: Less long-term clinical evidence than MTA, though rapidly accumulating

Calcium Hydroxide — Ca(OH)₂

Mechanism

Calcium hydroxide dissociates into calcium ions (Ca²⁺) and hydroxyl ions (OH⁻) in an aqueous environment. The hydroxyl ions create a highly alkaline pH of 12.5–12.8 — the primary basis for its biological effects:

• Antibacterial: High pH denatures bacterial cell membrane lipids, proteins, and DNA. Most endodontic pathogens are killed at pH above 11. However, Enterococcus faecalis is notably resistant to calcium hydroxide (can survive at pH 11.5 via its proton pump mechanism).
• Tissue dissolution: Limited compared to NaOCl, but OH⁻ denatures proteins — contributes to necrotic tissue dissolution over time.
• Reparative dentine induction: Ca²⁺ ions stimulate alkaline phosphatase activity and mineralisation; combined with mild irritation from OH⁻, induces tertiary dentine formation and dentine bridge. However, the bridge contains tunnel defects (see below).
• Anti-inflammatory: Inhibits PLA₂ and prostaglandin synthesis by denaturation; reduces inflammatory exudate.

Clinical Uses

• Intracanal medicament between appointments: Placed in the canal after shaping before obturation to suppress residual bacteria, particularly in necrotic/infected cases. The gold standard for 1–4 week intracanal dressing.
• External inflammatory resorption (post-avulsion): Immediate placement of calcium hydroxide throughout the root canal system after replantation of an avulsed tooth disrupts the blood supply to infected tubules that drives PDL resorption. Changed monthly until root canal treatment is completed.
• Apexification (open apex, non-vital): Long-term placement over 6–24 months induces an apical calcific barrier. Now largely replaced by MTA apical plug (faster, stronger).
• Pulp capping: Historically the standard; now second-line to MTA/Biodentine.
• Weeping canal / persistent exudate: Calcium hydroxide dressing absorbs periapical exudate; allows delayed obturation when persistent exudate prevents adequate sealer placement.

Limitations

• Tunnel defects: The dentine bridge formed under calcium hydroxide capping contains tunnel defects — gaps caused by localised necrosis at the high-pH interface between the material and pulp. These defects allow bacterial microleakage over time, reducing long-term success of DPC.
• Solubility: CaOH is water-soluble; it dissolves and washes out over time, losing the intracanal dressing effect. Sealed canals retain it longer, but it must be replaced if the tooth is inadvertently opened or the temporary seal fails.
• Ineffective against E. faecalis: A major limitation for intracanal use — E. faecalis resistance means persistent infections with this organism are not eliminated by CaOH alone. Supplemental irrigants (NaOCl, EDTA) and thorough mechanical preparation are required.
• Root weakening with long-term use: Extended placement of calcium hydroxide (>1 month, particularly with monthly replenishment over years as in old apexification protocols) has been associated with increased root fracture susceptibility, possibly due to proteolytic degradation of collagen in the dentine matrix by OH⁻.

Sodium Hypochlorite (NaOCl)

Sodium hypochlorite is the primary, irreplaceable endodontic irrigant. It is the only routinely used agent capable of dissolving organic tissue — both vital pulp and necrotic debris — while simultaneously providing broad-spectrum antibacterial activity.

Concentrations and Properties

• Available concentrations in endodontics: 0.5% (Dakin’s solution), 1%, 2.5%, 3%, 5.25% (household bleach strength). Most commonly used clinical concentrations: 2.5–5.25%.
• Mechanism: (1) Saponification — NaOCl reacts with fatty acids in cell membranes to form fatty acid salts (soap) and glycerol, disrupting membrane integrity. (2) Chlorination — hypochlorous acid (HOCl) chlorinates amino acids, inactivating cellular enzymes and denaturing proteins. (3) Osmotic effect — high pH and osmolarity disrupt bacterial water balance.
• Tissue dissolution: NaOCl dissolves organic tissue via hydrolysis — it breaks peptide bonds in protein chains. Higher concentration and higher temperature (warm NaOCl, 40–60°C) significantly increase dissolution rate. Inorganic component (mineral) of dentine is NOT dissolved by NaOCl — this is why EDTA is required to remove the inorganic smear layer component.
• Concentration vs toxicity trade-off: Higher NaOCl concentration = greater antimicrobial efficacy and faster tissue dissolution, but greater cytotoxicity to periapical tissues if extruded. 1–2% NaOCl is less cytotoxic; 5.25% is highly cytotoxic. Clinical decision involves balancing efficacy against risk. Warm NaOCl at lower concentration (e.g., warm 1–2%) can achieve similar dissolution to cold 5.25% with lower toxicity risk.

Sodium Hypochlorite Accident

Extrusion of NaOCl beyond the apex is a serious, potentially disfiguring complication. When NaOCl contacts periapical tissues:

• Immediate signs: Sudden, severe burning pain followed by swelling; rapid onset (within minutes to hours) of marked facial swelling (oedema) that may be dramatic in extent; possible ecchymosis (bruising) appearing within 12–24 hours as haemolysis occurs; possible taste of bleach by patient; possible paraesthesia.
• Management: Stop irrigation immediately. Remove rubber dam if in place to assess swelling. Apply ice packs to the affected area. Prescribe corticosteroids (dexamethasone) and NSAIDs for swelling and pain. Prescribe antibiotics (amoxicillin) as a precaution against secondary infection. Reassure the patient — the condition is typically self-limiting. Most cases resolve within 1–2 weeks as the tissue damage heals, though severe cases may leave scarring. Document fully and follow up closely.
• Prevention: Use rubber dam (mandatory). Use a side-vented (notched) needle rather than end-vented — this directs flow laterally, reducing pressure build-up. Do not bind the needle in the canal — the needle should sit passively and loosely in the canal. Irrigate with gentle, light pressure; if resistance is felt, withdraw the needle. Establish patency before irrigation. Use lower concentrations (1–2%) if the apex is open, the tooth is immature, or there is evidence of apical pathology that has perforated the cortex.

EDTA — Ethylenediaminetetraacetic Acid

EDTA (17% solution, pH 7.3) is a chelating agent that binds divalent cations (particularly Ca²⁺) from the inorganic component of dentine, primarily calcium hydroxyapatite. This removes the inorganic portion of the smear layer and opens dentinal tubule orifices.

• Primary use: Smear layer removal. The smear layer — a superficial layer of organic and inorganic debris created during canal instrumentation — occludes dentinal tubule orifices and prevents sealer penetration into tubules. EDTA chelates the inorganic component; NaOCl dissolves the organic component. Together they effectively remove the smear layer, improving the sealer-dentine interface and reducing residual bacteria within tubules.
• Protocol: NaOCl throughout instrumentation → EDTA final rinse (1–3 minutes, 5 mL or more per canal) → final NaOCl flush (removes EDTA residue and re-exposes the debrided surface). This sequence is critical.
• EDTA + NaOCl interaction: When EDTA and NaOCl are mixed simultaneously, they react to form N-chloro compounds (chloramines). This inactivates the free available chlorine in NaOCl, eliminating its antibacterial and dissolving properties. The mixture is cloudy and clinically ineffective. They must NEVER be mixed simultaneously. Use sequentially.
• Other uses: Lubricant during instrumentation of calcified canals (EDTA paste/gel such as RC-Prep, File-Eze); negotiation of calcified or ledged canals.
• Limitation: Extended contact (more than 3 minutes) causes erosion of peritubular and intertubular dentine, weakening the root canal wall. Use briefly; always follow with a final NaOCl flush.

Formocresol

Formocresol (FC) is a mixture of formaldehyde (19%) and tricresol (35%) in glycerol and water. It has been the most widely used pulpotomy medicament in primary teeth for over 70 years, originally at full concentration and later in diluted (1:5) form (Buckley’s formocresol).

• Mechanism: Formaldehyde fixes (cross-links) proteins in the radicular pulp — the pulp is not devitalised but rather chemically preserved. Tricresol provides additional antimicrobial activity. This fixation prevents bacterial degradation of the preserved pulp tissue, maintaining it as a sterile, fixed mass that does not provoke periapical inflammation.
• Technique (primary pulpotomy): Place a cotton pellet moistened in diluted (1:5) formocresol against the radicular pulp orifice for 5 minutes; remove and assess — if tissue is pink and firm (fixed), place ZOE base and restore with SSC. If tissue is haemorrhagic or black/grey, pulpotomy may be failing.
• Current status: Formocresol is no longer the preferred primary pulpotomy agent. Concerns include: formaldehyde is a known mutagen and carcinogen (IARC Group 1); systemic absorption through root apices; possible interference with permanent tooth development if large amounts are used. The AAPD now lists MTA, Biodentine, and ferric sulfate as preferred agents. Formocresol remains clinically acceptable when alternatives are unavailable.
• Note: NEVER use formocresol in permanent teeth — its fixation of vital pulp tissue is incompatible with pulp healing and dentine bridge formation.

Ferric Sulfate

Ferric sulfate (15.5% solution, e.g., Astringedent) is a haemostatic agent used in pulp therapy, particularly as a pulpotomy medicament in primary teeth.

• Mechanism: When applied to the cut pulp surface, ferric ions (Fe³⁺) react with blood proteins to form a ferric protein complex (agglutinated protein clot) that mechanically seals the blood vessels at the pulp wound. This is haemostasis by protein precipitation — the pulp tissue is NOT chemically fixed (unlike formocresol). The radicular pulp beneath the ferric sulfate layer remains biologically active.
• Advantages over formocresol: Not a mutagen or carcinogen. Does not release formaldehyde. Preserves radicular pulp viability rather than fixing it. Does not cause interference with the permanent successor.
• Disadvantages: Less long-term evidence than MTA/Biodentine for primary pulpotomy. The agglutinated protein layer may provoke an inflammatory reaction over time in some cases.
• Use in direct pulp capping: Ferric sulfate is sometimes used after achieving haemostasis (in the context of DPC or pulpotomy), but it is NOT a capping agent itself — it creates haemostasis and then MTA/Biodentine is placed over the treated site.

Medicament Comparison Summary

Clinical Considerations

• Irrigant sequence — order matters: The standard sequence for irrigation during root canal treatment is: NaOCl throughout instrumentation (organic dissolution + antibacterial) → EDTA final rinse (smear layer removal, chelation) → final NaOCl flush (removes EDTA, re-disinfects). Reversing this sequence or mixing EDTA and NaOCl simultaneously reduces the efficacy of both agents. The final NaOCl flush after EDTA is important to remove the chelated calcium-EDTA complexes and residual smear layer organic component.
• NaOCl concentration selection: For routine vital pulp cases (e.g., pulpectomy of a tooth with IRP), 2.5–5.25% NaOCl is appropriate. For avulsed teeth with open apices, immature teeth, or cases where periapical perforation is known, use 1–2% NaOCl and employ the needle passively — the risk of extrusion to highly cytotoxic concentrations is greater when the apical constriction is absent or compromised.
• Calcium hydroxide between appointments — duration: Calcium hydroxide intracanal dressings placed between appointments in infected/necrotic teeth should be changed if the tooth remains symptomatic at 1 month. For external inflammatory resorption post-avulsion, calcium hydroxide should be changed monthly and maintained until the root canal is obturated — typically 6–12 months depending on degree of resorption. Prolonged use (>3 months) without monitoring and appropriate management may increase root fracture risk.
• MTA moisture sensitivity: MTA requires moisture to set properly — it is a hydraulic cement. The pulp wound should have haemostasis achieved (no active bleeding) but should not be desiccated with prolonged air drying. A slightly moist environment is appropriate. Conversely, the cavity must not be flooded with moisture during MTA placement, as excess water dilutes the mix and reduces compressive strength.
• Warm NaOCl: Heating NaOCl to 40–60°C (warm but not scalding) significantly increases its tissue dissolution capacity and antimicrobial efficacy without increasing concentration. This is clinically useful when treating highly infected canals, avoiding the need to increase to higher and more cytotoxic concentrations. Commercial warmers (e.g., System B heater with an irrigant warming sleeve) or a warm water bath can be used.

Common Mistakes & Misconceptions

• Misconception: “EDTA and NaOCl can be alternated freely in any sequence.”
  Correction: They must never be mixed simultaneously — they inactivate each other. The correct sequence is NaOCl throughout instrumentation, then EDTA as a final rinse, then a final NaOCl flush. Alternating them rapidly (e.g., squirting one then immediately the other into the same canal) means they mix at the apical foramen or within the canal, generating chloramines and losing efficacy of both.
• Misconception: “Calcium hydroxide kills all endodontic bacteria.”
  Correction: Enterococcus faecalis is resistant to calcium hydroxide. This Gram-positive facultative anaerobe can maintain its intracellular pH via a proton pump, counteracting the external alkalinity. It is a major cause of endodontic treatment failure and persistent periapical infection. NaOCl and EDTA (removing its biofilm matrix) are more effective against E. faecalis. Supplemental disinfection with 2% chlorhexidine as a final rinse may provide additional efficacy.
• Misconception: “A NaOCl accident requires incision and drainage.”
  Correction: NaOCl accidents produce acute chemical burns and oedema, NOT a bacterial abscess requiring drainage. Incision into chemically injured, oedematous tissue without fluctuance is contraindicated — it causes additional tissue damage. Management is conservative: stop irrigation, ice application, corticosteroids, NSAIDs, monitoring. Incision and drainage is only appropriate if secondary bacterial infection develops with a fluctuant abscess, which is uncommon.
• Misconception: “Higher NaOCl concentration is always better.”
  Correction: Higher concentration provides better antimicrobial and tissue dissolution efficacy, but at the cost of greater cytotoxicity to periapical tissues if extruded, and greater tissue damage if a NaOCl accident occurs. Warm NaOCl at a lower concentration (1–2%) can achieve similar efficacy to cold 5.25% with substantially lower toxicity risk. Concentration selection should be proportional to case risk (open apex, known perforation, immature tooth = lower concentration).
• Misconception: “MTA setting time doesn’t affect the clinical protocol.”
  Correction: MTA takes 2.5–4 hours to set. If the pulp chamber is restored immediately after MTA placement, displacement of unset MTA is possible. For pulpotomy, after MTA placement a moist cotton pellet should be sealed over it for 24 hours (or at least one appointment), then the cotton pellet removed and the MTA verified as set and hard before placing the definitive composite build-up. Biodentine (12-minute set) avoids this limitation and can be restored immediately.

Related Topics

References & Sources

1. Torabinejad M, White DJ, 1995. Tooth-filling material and method of use. US Patent 5,415,547. Washington, DC: US Patent and Trademark Office.
2. Siqueira JF Jr, Lopes HP, 1999. Mechanisms of antimicrobial activity of calcium hydroxide: a critical review. International Endodontic Journal, 32(5), 361–369.
3. Haapasalo M, Endal U, Zandi H, Coil JM, 2005. Eradication of endodontic infection by instrumentation and irrigation solutions. Endodontic Topics, 10(1), 77–102.
4. Berman LH, Hargreaves KM, 2011. Cohen’s Pathways of the Pulp, 10th ed. Mosby/Elsevier.
5. Dentin H, Zehnder M, 2006. Chelating agents in root canal treatment: mode of action and indications for their use. Journal of Endodontics, 32(5), 395–402.
6. Torabinejad M, Hong CU, Ford TR, Kettering JD, 1995. Cytotoxicity of four root end filling materials. Journal of Endodontics, 21(10), 489–492.
7. Mohammadi Z, Soltani MK, Shalavi S, 2014. An update on the whys and wherefores of recontamination and repopulation of the root canal system by bacteria. Journal of Oral Science, 56(1), 9–16.
8. Parirokh M, Torabinejad M, 2010. Mineral trioxide aggregate: a comprehensive literature review — Part I: chemical, physical, and antibacterial properties. Journal of Endodontics, 36(1), 16–27.

Summary

Pulp therapy medicaments form the pharmacological foundation of endodontic practice. MTA and Biodentine are the preferred capping agents, producing superior dentine bridges and long-term outcomes compared to calcium hydroxide. Calcium hydroxide remains indispensable as an intracanal medicament for infected cases, external inflammatory resorption, and apexification — despite its solubility, tunnel defect formation, and inefficacy against E. faecalis. Sodium hypochlorite, the primary irrigant, is uniquely capable of dissolving organic tissue and must be used at appropriate concentrations with technique precautions to avoid extrusion. EDTA (17%) must be used sequentially with NaOCl — never simultaneously — to effectively remove the smear layer. Formocresol, while historically dominant in primary pulpotomy, has been replaced by MTA, Biodentine, and ferric sulfate in contemporary guidelines due to toxicity and carcinogenicity concerns.

About the Author

Dr. Andries Smith

Founder, Dental Panda

Dr. Andries Smith founded Dental Panda in 2020. As an immigrant to the United States, he had to take the INBDE exam, even though he was practicing dentistry for over 10 years. This revealed an opportunity. Andries noticed that INBDE prep course companies were putting profit over students. With his expertise and experience in dentistry, he created free dental wiki resources for students and the general public to have access to.